Protection against the metabolic syndrome by guar gum-derived short-chain fatty acids depends on peroxisome proliferator-activated receptor ? And Glucagon-like peptide-1

PLoS ONE

Volumn 10, Issue 8, 2015, Pages

  Den Besten, Gijs ^a,c,e   Gerding, Albert ^a   Van Dijk, Theo H ^b   Ciapaite, Jolita ^a   Bleeker, Aycha ^a,d   Van Eunen, Karen ^a,c,d   Havinga, Rick ^a   Groen, Albert K ^a,b,c,d   Reijngoud, Dirk Jan ^a,b,c,d   Bakker, Barbara M ^a,c,d  

^a UNIVERSITY OF GRONINGEN   (Netherlands)

^b UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^c Netherlands Consortium for Systems Biology   (Netherlands)

^d TOP INSTITUTE FOOD AND NUTRITION   (Netherlands)

^e ISALA HOSPITAL   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ADENYLATE KINASE; GLUCAGON LIKE PEPTIDE 1; GUAR GUM; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; SHORT CHAIN FATTY ACID; UNCOUPLING PROTEIN 2; GALACTAN; GLUCOSE BLOOD LEVEL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; MANNAN; PLANT GUM; VOLATILE FATTY ACID;

ADIPOSE TISSUE; AEROBIC METABOLISM; AMP ATP RATIO; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG MECHANISM; ENZYME ACTIVATION; GLUCOSE METABOLISM; GLUCOSE TOLERANCE; INSULIN RESISTANCE; INSULIN SENSITIVITY; LIPID METABOLISM; LIVER; MALE; METABOLIC PARAMETERS; METABOLIC SYNDROME X; MOLECULAR MODEL; MOUSE; NONHUMAN; OBESITY; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; ANALYSIS; ANIMAL; C57BL MOUSE; CECUM; CHEMISTRY; DIETARY FIBER; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE TEST; INDIRECT CALORIMETRY; METABOLISM; PHYSIOLOGY; THERAPEUTIC USE;

AMP-ACTIVATED PROTEIN KINASES; ANIMALS; BLOOD GLUCOSE; CALORIMETRY, INDIRECT; CECUM; DIETARY FIBER; FATTY ACIDS, VOLATILE; GALACTANS; GLUCAGON-LIKE PEPTIDE 1; GLUCOSE TOLERANCE TEST; INSULIN RESISTANCE; MALE; MANNANS; METABOLIC SYNDROME X; MICE; MICE, INBRED C57BL; PLANT GUMS; PPAR GAMMA;

EID: 84942892391     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0136364     Document Type: Article

References (48)

1. Galisteo M, Duarte J, Zarzuelo A. Effects of dietary fibers on disturbances clustered in the metabolic syndrome. J Nutr Biochem. 2008; 19: 71-84. PMID: 17618108
2. Misra A, Singhal N, Khurana L. Obesity, the Metabolic Syndrome, and Type 2 Diabetes in Developing Countries: Role of Dietary Fats and Oils. J Am Coll Nutr. 2010; 29: 289S-301S. PMID: 20823489
3. Papathanasopoulos A, Camilleri M. Dietary Fiber Supplements: Effects in Obesity and Metabolic Syndrome and Relationship to Gastrointestinal Functions. Gastroenterology. 2010; 138: 65-72. doi: 10. 1053/j.gastro.2009.11.045 PMID: 19931537
4. Landin K, Holm G, Tengborn L, Smith U. Guar gum improves insulin sensitivity, blood lipids, blood pressure, and fibrinolysis in healthy men. Am J Clin Nutr. 1992; 56: 1061-1065. PMID: 1442658
5. Dall'alba V, Silva FM, Antonio JP, Steemburgo T, Royer CP, Almeida JC, et al. Improvement of the metabolic syndrome profile by soluble fibre-guar gum-in patients with type 2 diabetes a randomised clinical trial. Br J Nutr. 2013; 110: 1601-1610. doi: 10.1017/S0007114513001025 PMID: 23551992
6. Cicero AFG, Derosa G, Bove M, Imola F, Borghi C, Gaddi AV. Psyllium improves dyslipidaemia, hyperglycaemia and hypertension, while guar gum reduces body weight more rapidly in patients affected by metabolic syndrome following an AHA Step 2 diet. Mediterr J Nutr Metab. 2010; 3: 47-57.
7. Krotkiewski M. Effect of guar gum on body-weight, hunger ratings and metabolism in obese subjects. Br J Nutr. 1984; 52: 97-105. PMID: 6331498
8. Flint HJ, Scott KP, Louis P, Duncan SH. The role of the gut microbiota in nutrition and health. Nat Rev Gastroenterol Hepatol. 2012; 9: 577-589. doi: 10.1038/nrgastro.2012.156 PMID: 22945443
9. den Besten G, van Eunen K, Groen AK, Venema K, Reijngoud D, Bakker BM. The role of short-chain fatty acids in the interplay between diet, gut microbiota and host energy metabolism. J Lipid Res. 2013; 54: 2325-2340. doi: 10.1194/jlr.R036012 PMID: 23821742
10. den Besten G, Havinga R, Bleeker A, Rao S, Gerding A, van Eunen K, et al. The Short-Chain Fatty Acid Uptake Fluxes by Mice on a Guar Gum Supplemented Diet Associate with Amelioration of Major Biomarkers of the Metabolic Syndrome. PLoS ONE. 2014; 9: E107392. doi: 10.1371/journal.pone. 0107392 PMID: 25203112
11. Gao Z, Yin J, Zhang J, Ward RE, Martin RJ, Lefevre M, et al. Butyrate Improves Insulin Sensitivity and Increases Energy Expenditure in Mice. Diabetes. 2009; 58: 1509-1517. doi: 10.2337/db08-1637 PMID: 19366864
12. Lin HV, Frassetto A, Kowalik EJJ, Nawrocki AR, Lu MM, Kosinski JR, et al. Butyrate and Propionate Protect against Diet-Induced Obesity and Regulate Gut Hormones via Free Fatty Acid Receptor 3-Independent Mechanisms. PLoS ONE. 2012; 7: E35240. doi: 10.1371/journal.pone.0035240 PMID: 22506074
13. den Besten G, Bleeker A, Gerding A, van Eunen K, Havinga R, van Dijk TH, et al. Short-Chain Fatty Acids protect against High-Fat Diet-Induced Obesity via a PPAR-dependent switch from lipogenesis to fat oxidation. Diabetes. 2015; 64: 2398-2408. doi: 10.2337/db14-1213 PMID: 25695945
14. Bligh EG, Dyer WJ. A rapid method of total lipid extraction and purification. Can J Biochem Physiol. 1959; 37: 911-917. PMID: 13671378
15. Oosterveer MH, van Dijk TH, Tietge UJ, Boer T, Havinga R, Stellaard F, et al. High Fat Feeding Induces Hepatic Fatty Acid Elongation in Mice. PLoS One. 2009; 4: E6066. doi: 10.1371/journal.pone.0006066 PMID: 19557132
16. Hirschey MD, Shimazu T, Goetzman E, Jing E, Schwer B, Lombard DB, et al. SIRT3 regulates fatty acid oxidation via reversible enzyme deacetylation. Nature. 2010; 464: 121-125. doi: 10.1038/nature08778 PMID: 20203611
17. Miller RA, Chu Q, Xie J, Foretz M, Viollet B, Birnbaum MJ. Biguanides suppress hepatic glucagon signalling by decreasing production of cyclic AMP. Nature. 2013; 494: 256-260. doi: 10.1038/nature11808 PMID: 23292513
18. Kuznetsov AV, Lassnig B, Stadlmann S, Rieger G, Gnaiger E. Selected media and chemicals for respirometry with mitochondria and permeabilized cells. OROBOROS Bioenerg News. 1998; 3: 1-9.
19. Grefhorst A, van Dijk TH, Hammer A, van der Sluijs FH, Havinga R, Havekes LM, et al. Differential effects of pharmacological liver X receptor activation on hepatic and peripheral insulin sensitivity in lean and ob/ob mice. Am J Physiol Endocrinol Metab. 2005; 289: E829-E838. PMID: 15941783
20. Mildaziene V, Nauciene Z, Baniene R, Grigiene J. Multiple Effects of 2, 2', 5, 5'-Tetrachlorobiphenyl on Oxidative Phosphorylation in Rat Liver Mitochondria. Toxicol Sci. 2002; 65: 220-227. PMID: 11812926
21. Gnaiger E, Kuznetsov AV, Schneeberger S, Seiler R, Brandacher G, Steurer W, et al. Mitochondria in the cold. In: Heldmaier G, Klingenspor M, editors. Life in the Cold.: Springer; 2000. pp. 431-442.
22. den Besten G, Lange K, Havinga R, van Dijk TH, Gerding A, van Eunen K, et al. Gut-derived shortchain fatty acids are vividly assimilated into host carbohydrates and lipids. Am J Physiol Gastrointest Liver Physiol. 2013; 305: G900-910. doi: 10.1152/ajpgi.00265.2013 PMID: 24136789
23. National Academy of Sciences. Dietary, functional, and total fiber. In: Anonymous Dietary Reference Intakes for Energy, Carbohydrate, Fiber, Fat, Fatty Acids, Cholesterol, Protein, and Amino Acids (Macronutrients). Washington, D.C.: National Academies Press; 2005. pp. 339-400.
24. Bergman EN. Energy contributions of volatile fatty acids from the gastrointestinal tract in various species. Physiol Rev. 1990; 70: 567-590. PMID: 2181501
25. Cannon B, Nedergaard J. Studies of thermogenesis and mitochondrial function in adipose tissues. Methods Mol Biol. 2008; 456: 109-121. doi: 10.1007/978-1-59745-245-8-8 PMID: 18516556
26. Carling D, Mayer FV, Sanders MJ, Gamblin SJ. AMP-Activated protein kinase: Nature's energy sensor. Nat Chem Biol. 2011; 7: 512-518. doi: 10.1038/nchembio.610 PMID: 21769098
27. Foretz M, Carling D, Guichard C, Ferré P, Foufelle F. AMP-Activated protein kinase inhibits the glucose-Activated expression of fatty acid synthase gene in rat hepatocytes. J Biol Chem. 1988; 273: 14767-14771.
28. Leclerc I, Kahn A, Doiron B. The 5'-AMP-Activated protein kinase inhibits the transcriptional stimulation by glucose in liver cells, acting through the glucose response complex. FEBS Lett. 1998; 431: 180-184. PMID: 9708898
29. van den Hoek AM, Heijboer AC, Corssmit EPM, Voshol PJ, Romijn JA, Havekes LM, et al. PYY3-36 Reinforces Insulin Action on Glucose Disposal in Mice Fed a High-Fat Diet. Diabetes. 2004; 53: 1949-1952. PMID: 15277371
30. Barrera JG, Sandoval DA, D'Alessio DA, Seele RJ. GLP-1 and energy balance: An integrated model of short-Term and long-Term control. Nat Rev Endocrinol. 2011; 7: 507-516. doi: 10.1038/nrendo.2011.77 PMID: 21647189
31. Meier JJ. GLP-1 receptor agonists for individualized treatment of type 2 diabetes mellitus. Nat Rev Endocrinol. 2012; 8: 728-742. doi: 10.1038/nrendo.2012.140 PMID: 22945360
32. Tolhurst G, Heffron H, Lam YS, Parker HE, Habib AM, Diakogiannaki E, et al. Short-Chain Fatty Acids Stimulate Glucagon-Like Peptide-1 Secretion via the G-Protein-Coupled Receptor FFAR2. Diabetes. 2011; 61: 364-371. doi: 10.2337/db11-1019 PMID: 22190648
33. Freeland KR, Wolever TM. Acute effects of intravenous and rectal acetate on glucagon-like peptide-1, peptide YY, ghrelin, adiponectin and tumour necrosis factor-Alpha. Br J Nutr. 2010; 103: 460-466. doi: 10.1017/S0007114509991863 PMID: 19818198
34. Uusitupa M, Siitonen O, Savolainen K, Silvasti M, Penttilä I, Parviainen M. Metabolic and nutritional effects of long-Term use of guar gum in the treatment of noninsulin-dependent diabetes of poor metabolic control. Am J Clin Nutr. 1989; 49: 345-351. PMID: 2537003
35. Smith U, Holm G. Effect of a modified guar gum preparation on glucose and lipid levels in diabetics and healthy volunteers. Atherosclerosis. 1982; 45: 1-10. PMID: 6297515
36. Ebeling P, Yki-Järvinen H, Aro A, Helve E, Sinisalo M, Koivisto VA. Glucose and lipid metabolism and insulin sensitivity in type 1 diabetes the effect of guar gum. Am J Clin Nutr. 1988; 48: 98-103. PMID: 3291601
37. Murphy KG, Bloom SR. Gut hormones and the regulation of energy homeostasis. Nature. 2006; 444: 854-859. PMID: 17167473
38. D'Alessio DA, Kahn SE, Leusner CR, Ensinck JW. Glucagon-like peptide 1 enhances glucose tolerance both by stimulation of insulin release and by increasing insulin-independent glucose disposal. J Clin Invest. 1994; 93: 2263-2266. PMID: 8182159
39. Burcelin R, Da Costa A, Drucker D, Thorens B. Glucose competence of the hepatoportal vein sensor requires the presence of an activated glucagon-like peptide-1 receptor. Diabetes. 2001; 50: 1720-1728. PMID: 11473030
40. Ionut V, Hucking K, Liberty IF, Bergman RN. Synergistic effect of portal glucose and glucagon-like peptide-1 to lower systemic glucose and stimulate counter-regulatory hormones. Diabetologia. 2005; 48: 967-975. PMID: 15830188
41. Brown AJ, Goldsworthy SM, Barnes AA, Eilert MM, Tcheang L, Daniels D, et al. The Orphan G Proteincoupled Receptors GPR41 and GPR43 Are Activated by Propionate and Other Short Chain Carboxylic Acids. J Biol Chem. 2003; 278: 11312-11319. PMID: 12496283
42. Le Poul E, Loison C, Struyf S, Springael JY, Lannoy V, Decobecq ME, et al. Functional Characterization of Human Receptors for Short Chain Fatty Acids and Their Role in Polymorphonuclear Cell Activation. J Biol Chem. 2003; 278: 25481-25489. PMID: 12711604
43. Topping DL, Clifton PM. Short-Chain Fatty Acids and Human Colonic Function: Roles of Resistant Starch and Nonstarch Polysaccharides. Physiol Rev. 2001; 81: 1031-1064. PMID: 11427691
44. Galisteo M, Duarte J, Zarzuelo A. Effects of dietary fibers on disturbances clustered in the metabolic syndrome. J Nutr Biochem. 2008; 19: 71-84. PMID: 17618108
45. Bingham SA, Day NE, Luben R, Ferrari P, Slimani N, Norat T, et al. Dietary fibre in food and protection against colorectal cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC): An observational study. The Lancet. 2003; 361: 1496-1501.
46. Nicholson JK, Holmes E, Kinross J, Burcelin R, Gibson G, Jia W, et al. Host-Gut Microbiota Metabolic Interactions. Science. 2012; 336: 1262-1267. doi: 10.1126/science.1223813 PMID: 22674330
47. Holmes E, Li JV, Marchesi JR, Nicholson JK. Gut microbiota composition and activity in relation to host metabolic phenotype and disease risk. Cell Metab. 2012; 16: 559-564. doi: 10.1016/j.cmet.2012.10. 007 PMID: 23140640
48. Claus SP, Ellero SL, Berger B, Krause L, Bruttin A, Molina J, et al. Colonization-Induced Host-Gut Microbial Metabolic Interaction. MBio. 2011; 2: E00271-e00281. doi: 10.1128/mBio.00271-10 PMID: 21363910